Summary
Levels of chemiluminescence were measured in peripheral blood mononuclear cells (PBMC) from normal subjects and from solid tumor cancer patients. Patients with advanced malignant disease were found to have significantly elevated baseline chemiluminescence activity in their ‘resting PBMC’ as compared to normal subjects or to cancer patients with, at most, minimum residual disease. Patients with either advanced disease or minimum residual disease, however, were found to exhibit significantly elevated activation of chemiluminescence by treatment of cells with phorbol myristic acetate (PMA). Treatment of surgically resected stage I lung cancer patients with Freund's complete adjuvant alone or emulsified with extracted lung cancer antigens was found to elevate chemiluminescence levels in patient PBMC. Serum from those vaccinated patients was found to elevate chemiluminescence levels of resting PBMC from normal subjects. That serum activity did net correlate with levels of immune complexes measurable in the Clq or Raji cell assay.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Allen RC (1977) Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes. Infect Immun 15:828
Allen RC (1980a) Chemiluminescence: An approach to the study of the humoral-phagocyte axis in host defense against infection. In: Peng CT, Harrocks DL, Alpen EL (eds) Liquid scintillation: Recent applications and developments. Academic Press, New York, pp 377–393
Allen RC (1980b) Free-radical production by reticuloendothelial cells. In: Sbarra AJ, Strauss R (eds) The reticuloendothelial system, vol 2. Plenum Press, New York, pp 309–338
Allen RC, Lint TF (1979) Correlation of chemiluminescence to microbicidal metabolic responses from polymorphonuclear leukocytes: a study of in vitro aging. In: Proceedings of the International Symposium on Analytical Application of Bioluminescence and Chemiluminescence. State Printing and Publishing, Westlake Village, pp 589–600
Allen RC, Stjernholm RL, Steele RH (1972) Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47:679–684
Allen RC, Stjernholm RL, Reed MA, Harper TB III, Gupta S, Steele RH, Waring WW (1977) Correlation of metabolic and chemiluminescent responses of granulocytres from three female siblings with chronic granulomatous disease. J Infect Dis 136:510–518
Braun DP, Harris JE (1981) Monocyte suppression and activation in solid tumor cancer patients. Proc Am Assoc Cancer Res 22:185
Braun DP, Cobleigh MA, Harris JE (1980) Multiple concurrent immunoregulatory defects in cancer patients with depressed PHA-induced lymphocyte DNA synthesis. Clin Immunol Immunopathol 17:89–101
Catalona WJ, Taylor SPT, Rabson AS, Cretian PB (1972) A method of dinitrochlorobenzine contact sensitization. A clinicopathological study. N Engl J Med 286:399
Cohn ZA (1978) The activation of mononuclear phagocytes: Fact, fancy, and future. J Immunol 121:813
Drath DB, Karnovsky ML (1975) Superoxide production by phagocytic leukocytes. J Exp Med 141:257
Grebner JV, Mills EL, Gray BH, Quie PG (1977) Comparison of phagocytic and chemiluminescence response of human polymorphonuclear neutrophils. J Lab Clin Med 89:153–159
Hay FC, Nineham LJ, Roitt IM (1977) Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase Clq. Clin Exp Immunol 24:395–400
Hibbs JB (1975) Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen. Transplantation 19:77–81
Jerrells TR, Dean JH, Richardson G, Cannon GB, Herberman RB (1979) Increased monocyte-mediated cytostatis of lymphoid cell lines in breast and lung cancer patients. Int J Cancer 239:768
Johnson RB Jr, Lehmeyer JE, Guthrie LA (1976) Generation of superoxide anion and chemiluminescence by human monocyte during phagocytosis and on contact with surface bound immunoglobulin G. J Exp Med 143:1551–1556
Meltzer MS, Stevenson MM (1977) Macrophage function in tumor-bearing mice: Tumoricidal and chemotactic response of macrophages activated by infection with mycobacterium bovis strain BCG. J Immunol 118:2176
Meltzer MS, Stevenson M (1978) Macrophage function in tumor-beraring mice: Dissociation of phagocytic and chemotactic responsiveness. Cell Immunol 35:99
Mitchell MS, Mokyr MB, Kahane I (1975) Stimulation of lymphoid cells by components of BCG. J Natl Cancer Inst 55:1337
Nelson RD, Mills EL, Simmons RL, Quie PG (1976) Chemiluminescence response of phagocytizing human monocytes. Infect Immun 14:129–134
Oehler JR, Herberman RB, Holden HT (1978) Modulation of immunity by macrophages. Pharmacol Ther 2:551
Poleshuck LC, Strausser HR (1980) Immune-complex induced prostaglandin production by monocytes of normal human subjects and cancer patients. Prostaglandins Med 4:363–375
Ruco LP, Meltzer MS (1978) Macrophage activation for tumor cytotoxicity: Increased lymphokine responsiveness of peritoneal macrophage during acute inflammation. J Immunol 120:1054
Samak R, Israel L, Edelstein R (1980) Influence of tumor burden, tumor removal, immune stimulation, plasmapheresis on monocyte mobilization in cancer patients. In: Friedman H (ed) Proceedings of the Eighth International Congress of the Reticuloendothelial Society. Plenum Press, New York, p 411
Schleupner CJ, Glasgow LA (1978) Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infect Immun 21:886–895
Sheagren HN, Block HB, Wolf SM (1967) Reticuloendothelial system phagocytic function in patients with Hodgkins disease. J Clin Invest 46:855
Siegel BV (1976) The macrophage and cancer. J Reticuloendothel Soc 20:219
Stewart T, Hollinshead A, Harris JE, et al. (1979) Specific active immunochemotherapy in lung cancer: A survival study. Recent Results Cancer Res 68:278
Theofilopoulos AN, Dixon FJ (1979) The biology and detection of immune complexes. Adv Immunol 28:89
Theofilopoulos AN, Wilson CB, Dixon FJ (1976) The Raji cell radioimmunoassay for detecting immune complexes in human sera. J Clin Invest 57:169–182
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braun, D.P., Harris, J.E., Maximovich, S. et al. Chemiluminescence in peripheral blood mononuclear cells of solid tumor cancer patients. Cancer Immunol Immunother 12, 31–37 (1981). https://doi.org/10.1007/BF00200309
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200309